FR940922-1-00082 FR940922-1-00009 21. Section 807.100 is amended by redesignating paragraph (a)(4) as (a)(5) and adding new paragraph (a)(4) to read as follows: §807.100 FDA action on a premarket notification. (a) *␣*␣* (4) Withhold the decision until a certification or disclosure statement is submitted to FDA pursuant to part 54 of this chapter. * * * * * PART 812_INVESTIGATIONAL DEVICE EXEMPTIONS 22. The authority citation for 21 CFR part 812 continues to read as follows: Authority: Secs. 301, 501, 502, 503, 505, 506, 507, 510, 513&hyph;516, 518&hyph;520, 701, 702, 704, 706, 801 of the Federal Food, Drug and Cosmetic Act (21 U.S.C. 331, 351, 352, 353, 355, 356, 357, 360, 360c&hyph;360f, 360h&hyph;360j, 371, 372, 374, 376, 381); secs. 215, 301, 351, 354&hyph;360F of the Public Health Service Act (42 U.S.C. 216, 241, 262, 263b&hyph;263n). * * * * * 23. Section 812.110 is amended by redesignating paragraph (d) as (e) and adding new paragraph (d) to read as follows: §812.110 Specific responsibilities of investigators. * * * * * (d) Financial disclosure. An investigator shall disclose to the sponsor sufficient accurate financial information to allow the sponsor to submit complete and accurate certification or disclosure statements required under part 54 of this chapter. The investigator shall promptly update this information if any relevant changes occur during the course of the investigation. * * * * * PART 814_PREMARKET APPROVAL OF MEDICAL DEVICES 24. The authority citation for 21 CFR part 814 continues to read as follows: Authority: Secs. 501, 502, 503, 510, 513&hyph;520, 701, 702, 703, 704, 705, 706, 708, 801 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 351, 352, 353, 360, 360c&hyph;360j, 371, 372, 373, 374, 375, 376, 379, 381). 25. Section 814.20 is amended by redesignating paragraph (b)(12) as (b)(13) and adding new paragraph (b)(12) to read as follows: §814.20 Application. (b) *␣*␣* (12) A financial certification or disclosure statement as required by part 54 of this chapter. * * * * * 26. Section 814.42 is amended by adding new paragraph (e)(5) follows: §814.42 Filing of PMA. * * * * * (e) *␣*␣* (5) The PMA is not accompanied by a statement of either certification or disclosure pursuant to part 54 of this chapter. PART 860_MEDICAL DEVICE CLASSIFICATION PROCEDURES 27. The authority citation for 21 CFR part 860 continues to read as follows: Authority: Secs. 513, 514, 515, 519, 520, 701, 704 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360c, 360d, 360e, 360i, 360j, 371, 374). 28. Section 860.123 is amended by adding new paragraph (a)(10) to read as follows: §860.123 Reclassification section: Content and form. (a) *␣*␣* (10) A financial certification or disclosure statement as required by part 54 of this chapter. * * * * * Dated: September 13, 1994. David A. Kessler, Commissioner of Food and Drugs. Donna E. Shalala, Secretary of Health and Human Services. [FR Doc. 94&hyph;23414 Filed 9&hyph;21&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;P
